GlaxoSmithKline plc (GSK) Given a GBX 1,610 Price Target at Deutsche Bank AG

Deutsche Bank AG set a GBX 1,610 ($20.90) price target on GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Tuesday, August 8th. The brokerage currently has a neutral rating on the stock.

GSK has been the subject of several other research reports. Beaufort Securities upped their target price on shares of GlaxoSmithKline plc from GBX 1,750 ($22.72) to GBX 2,000 ($25.96) and gave the stock a buy rating in a research report on Thursday, June 1st. Shore Capital restated a hold rating on shares of GlaxoSmithKline plc in a research report on Friday, June 2nd. Liberum Capital reiterated a buy rating and issued a GBX 1,900 ($24.67) price objective on shares of GlaxoSmithKline plc in a report on Tuesday, June 6th. S&P Global set a GBX 1,500 ($19.47) price objective on shares of GlaxoSmithKline plc and gave the company a sell rating in a report on Tuesday, June 6th. Finally, Jefferies Group LLC increased their price objective on shares of GlaxoSmithKline plc from GBX 1,800 ($23.37) to GBX 1,900 ($24.67) and gave the company a buy rating in a report on Friday, June 16th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of GBX 1,724 ($22.38).

GlaxoSmithKline plc (LON GSK) traded down 1.06% on Tuesday, hitting GBX 1490.00. The stock had a trading volume of 7,080,333 shares. GlaxoSmithKline plc has a 52-week low of GBX 1,446.50 and a 52-week high of GBX 1,745.56. The company’s market cap is GBX 72.83 billion. The company has a 50 day moving average price of GBX 1,564.93 and a 200-day moving average price of GBX 1,621.93.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by BNB Daily and is owned by of BNB Daily. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/glaxosmithkline-plc-gsk-given-a-gbx-1610-price-target-at-deutsche-bank-ag-updated.html.

The business also recently announced a dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, August 10th will be paid a GBX 19 ($0.25) dividend. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.

In other GlaxoSmithKline plc news, insider Victoria Whyte sold 4,820 shares of the company’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of GBX 1,693 ($21.98), for a total transaction of £81,602.60 ($105,936.13). Also, insider Manvinder Singh Banga acquired 2,267 shares of GlaxoSmithKline plc stock in a transaction on Wednesday, July 26th. The shares were purchased at an average price of GBX 1,599 ($20.76) per share, for a total transaction of £36,249.33 ($47,058.72). Over the last ninety days, insiders acquired 3,151 shares of company stock valued at $5,054,922.

About GlaxoSmithKline plc

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply